Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 2686 AL 2700

Mitochondria targeted nanoparticles for the treatment of mitochondrial dysfunction-associated brain disorders

Buck AC, Maarman GJ, Dube A, Bardien S.

Front Bioeng Biotechnol. 2025 Mar 12;13:1563701. doi: 10.3389/fbioe.2025.1563701. eCollection 2025.

Neuroplastic effects of transcranial alternating current stimulation (tACS): from mechanisms to clinical trials

Agboada D, Zhao Z, Wischnewski M.

Front Hum Neurosci. 2025 Mar 12;19:1548478. doi: 10.3389/fnhum.2025.1548478. eCollection 2025.

Imaging the enteric nervous system

Hazart D, Moulzir M, Delhomme B, Oheim M, Ricard C.

Front Neuroanat. 2025 Mar 12;19:1532900. doi: 10.3389/fnana.2025.1532900. eCollection 2025.

Neuropsychological Tests of Memory, Visuospatial, and Language Function in Parkinson's Disease: Review, Critique, and Recommendations

Bezdicek O, Biundo R, Boelema S, Cammisuli DM, Cholerton B, Cronin-Golomb A, Dalrymple-Alford JC, Duits A, Fellows R, Gerstenecker A, El Hachioui H, Horáková H, Koerts J, Levin B, Liepelt-Scarfone I, Sarno M, Mestre TA, Ferro ÁS, de Siqueira Tosin MH, Skorvanek M, Weintraub D, Geurtsen GJ; members of the IPMDS Clinical Outcome Assessment Scientific Evaluation Committee.

Mov Disord. 2025 May;40(5):795-806. doi: 10.1002/mds.30166. Epub 2025 Mar 27.

Association between dapagliflozin and risk of dementia and Parkinson's disease: a subgroup analysis of a meta-analysis of randomized controlled trials

Fernandes JV, Ramos JV, Holanda MM.

Minerva Med. 2025 Aug;116(4):323-328. doi: 10.23736/S0026-4806.25.09695-8. Epub 2025 Mar 27.

Olfactory changes in patients with Parkinson's disease undergoing deep brain stimulation in the subthalamic nucleus: a systematic review and meta-analysis

Pereira MAOM, Ferreira MY, Sousa MP, Paula IDR, Ribeiro VEA, Soares VG, de Oliveira CMM, Gonçalves OR, Ribeiro FV, Junior SGC, Pereira AFM, Parmera JB, Portela DMMC, Brito HN, Noleto GS.

Neurosurg Rev. 2025 Mar 27;48(1):333. doi: 10.1007/s10143-025-03479-0.

Pharmacologic treatments for gastroparesis

Camilleri M, Jencks KJ.

Pharmacol Rev. 2025 Mar;77(2):100019. doi: 10.1016/j.pharmr.2024.100019. Epub 2024 Nov 23.

Neuroglia in neurodegeneration: Alzheimer, Parkinson, and Huntington disease

Lim D, Matute C, Cavaliere F, Verkhratsky A.

Handb Clin Neurol. 2025;210:9-44. doi: 10.1016/B978-0-443-19102-2.00012-0.

Innovations and ongoing challenges in digital technologies for Parkinson's disease

Roemmich RT, Moro E, Shull PB.

NPJ Parkinsons Dis. 2025 Mar 27;11(1):60. doi: 10.1038/s41531-025-00920-5.

Neurofilament Light Chain in Cerebrospinal Fluid and Blood in Multiple System Atrophy: A Systematic Review and Meta-Analysis

Demiri S, Veltsista D, Siokas V, Spiliopoulos KC, Tsika A, Stamati P, Chroni E, Dardiotis E, Liampas I.

Brain Sci. 2025 Feb 25;15(3):241. doi: 10.3390/brainsci15030241.

Vocal Feature Changes for Monitoring Parkinson's Disease Progression-A Systematic Review

Wright H, Aharonson V.

Brain Sci. 2025 Mar 19;15(3):320. doi: 10.3390/brainsci15030320.

Olfactory Dysfunction as a Clinical Marker of Early Glymphatic Failure in Neurodegenerative Diseases

Sánchez-Benavides G, Iranzo A, Grau-Rivera O, Giraldo DM, Buongiorno M.

Diagnostics (Basel). 2025 Mar 13;15(6):719. doi: 10.3390/diagnostics15060719.

AZP2006 (Ezeprogind(®)): a Promising New Drug Candidate in the Battle Against Neurodegenerative Diseases

Verwaerde P, Defert O.

ChemMedChem. 2025 May 19;20(10):e202400891. doi: 10.1002/cmdc.202400891. Epub 2025 Mar 27.

Feasibility and acceptability of PDConnect, a multi-component intervention to support physical activity in people with Parkinson's disease: A mixed methods study

Jones J, Alexander L, Hancock E, Cooper K.

J Parkinsons Dis. 2025 May;15(3):603-618. doi: 10.1177/1877718X251324415. Epub 2025 Mar 28.

Therapeutic potential and challenges of mesenchymal stem cells in neurological disorders: A concise analysis

Issa EHB, Alghazo EM, Gharaibeh R, Momani NB, Taha DZ, Jaradat RJ, Alzu'bi A, Almahasneh FA, Abu-El-Rub E, Al-Zoubi RM.

J Neuropathol Exp Neurol. 2025 Aug 1;84(8):668-679. doi: 10.1093/jnen/nlaf021.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias